{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:49:06Z","timestamp":1791341346621,"version":"4.3.1"},"reference-count":69,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T00:00:00Z","timestamp":1103500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK59809-01"],"award-info":[{"award-number":["DK59809-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL\/DK 71215-01"],"award-info":[{"award-number":["HL\/DK 71215-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Nitrosative stress, that is, enhanced peroxynitrite formation, has been documented in both experimental and clinical diabetic neuropathy (DN), but its pathogenetic role remains unexplored. This study evaluated the role for nitrosative stress in two animal models of type 1 diabetes: streptozotocin\u2010diabetic mice and diabetic NOD mice. Control (C) and streptozotocin\u2010diabetic (D) mice were treated with and without the potent peroxynitrite decomposition catalyst FP15 (5 mg kg\n                    <jats:sup>\u22121<\/jats:sup>\n                    d\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) for 1 wk after 8 wk without treatment. Sciatic nerve nitrotyrosine (a marker of peroxynitrite\u2010induced injury) and poly(ADP\u2010ribose) immunoreactivities were present in D and absent in C and D+FP15. FP15 treatment corrected sciatic motor and hind\u2010limb digital sensory nerve conduction deficits and sciatic nerve energy state in D, without affecting those variables in C. Nerve glucose and sorbitol pathway intermediate concentrations were similarly elevated in D and D+FP15 vs C. In diabetic NOD mice, a 7\u2010day treatment with either 1 or 3 mg kg\n                    <jats:sup>\u22121<\/jats:sup>\n                    d\n                    <jats:sup>\u22121<\/jats:sup>\n                    FP15 reversed increased tail\u2010flick latency (a sign of reduced pain sensitivity); the effect of the higher dose was significant as early as 3 days after beginning of the treatment. In conclusion, nitrosative stress plays a major role in DN in, at least, type 1 diabetes. This provides the rationale for development of agents counteracting peroxynitrite formation and promoting peroxynitrite decomposition, and their evaluation in DN.\n                  <\/jats:p>","DOI":"10.1096\/fj.04-1913fje","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T20:14:36Z","timestamp":1103573676000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst"],"prefix":"10.1096","volume":"19","author":[{"given":"Irina G.","family":"Obrosova","sequence":"first","affiliation":[{"name":"Department of Internal Medicine University of Michigan  Ann Arbor MI"},{"name":"Pennington Biomedical Research Center Louisiana State University System  Baton Rouge LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon G.","family":"Mabley","sequence":"additional","affiliation":[{"name":"Inotek Pharmaceuticals Corporation  Beverly MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Zsengell\u00e9r","sequence":"additional","affiliation":[{"name":"Inotek Pharmaceuticals Corporation  Beverly MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Charniauskaya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Michigan  Ann Arbor MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omorodola I.","family":"Abatan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Michigan  Ann Arbor MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Groves","sequence":"additional","affiliation":[{"name":"Department of Chemistry Princeton University  Princeton NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"Inotek Pharmaceuticals Corporation  Beverly MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1458"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2563"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.10.1776"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1096\/fj.01-0603fje","article-title":"An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense","volume":"16","author":"Obrosova I. G.","year":"2002","journal-title":"FASEB J."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.7.1851"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(02)50072-6"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.10.2090"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.10.953"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.9.2372"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(02)50071-4"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1927"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704216"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/414813a"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(03)00508-3"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100626"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.9.2363"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.9.2817"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402167"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/83241"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.3.375"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(02)00508-8"},{"key":"e_1_2_6_23_1","first-page":"1","volume-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","author":"Groves J. T.","year":"2004"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja00142a032"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja980507y"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.2247"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1367-5931(99)80036-2"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14243"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.3.711"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051290"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.6.1006"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00137-5"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.770"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01109.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1996.510601.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.165"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0253hyp"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051638"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00418340"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/1071576021000028442"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402168"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000048192.52098.DD"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01566-7"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200002)43:2<320::AID-ANR11>3.0.CO;2-9"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.3.386"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(00)00164-9"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00528-6"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400086"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050131"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.8.1160"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050921"},{"key":"e_1_2_6_52_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s001250050996","article-title":"A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy","volume":"41","author":"Hounsom L.","year":"1998","journal-title":"Diabetologia"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(94)00195-P"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00658-X"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63565-1"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1463-y"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(97)10109-3"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1356-0"},{"issue":"2","key":"e_1_2_6_59_1","first-page":"A213","article-title":"Aldose reductase inhbitor fidarestat counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in experimental diabetic neuropathy","volume":"53","author":"Obrosova I. G.","year":"2004","journal-title":"Diabetes"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00343.2001"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.3.864"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1022"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-003-0005-1"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.052712399"},{"key":"e_1_2_6_65_1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1096\/fj.03-0013fje","article-title":"Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation","volume":"17","author":"Minchenko A. G.","year":"2003","journal-title":"FASEB J."},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(02)00892-4"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.3109\/10715769809065804"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2003.11.002"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1006\/niox.2001.0419"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814489"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-1913fje","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.04-1913fje","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.04-1913fje","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:03:01Z","timestamp":1761670981000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.04-1913fje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,20]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1096\/fj.04-1913fje"],"URL":"https:\/\/doi.org\/10.1096\/fj.04-1913fje","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,20]]},"assertion":[{"value":"2004-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}